Objectives

• Achieve P&R, HTA recommendations, and Formulary inclusion at optimal prices/restrictions

Activities

• Final Pricing Strategy
• Launch
  • Negotiation guide
  • Core Value Dossier
  • Adaptation Core Value Dossier to Local Needs
  • Strategic advice
• Negotiation Skills and Strategy
• Life Cycle
  • Price database; Coordination sequence; Price Erosion
  • HEOR/Epidemiology
    • Launch
      • FDA/EMEA PRO submission dossier
      • Publication HEOR evidence (Cost-effectiveness, comparative effectiveness, clinical relevance, Phase III HEOR results)
      • Standard HTA dossier
      • Local Adaptation (Cost-effectiveness and local HTA Dossier)
      • HE studies
      • Post-hoc analyses
      • Publications
    • Life Cycle
      • IITs; real life effectiveness
      • Scientific Lobbying
      • Anticipate re-evaluation and update HTA dossier
      • Monitor New entrants/Environment
• Interaction Affiliates Region and corporate functions for successful market access

Workshop & Case study